2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
9
Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Multiple Myeloma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Rectal Neoplasms
2
Radiation Injuries
2
Prostatic Neoplasms
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms by Histologic Type
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Chronic Conditions
2
Melanoma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Lung Neoplasms
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Leukemia, Biphenotypic, Acute
2
Interventions
Ultrasonic Waves
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Surveys and Questionnaires
1
Patient Reported Outcome Measures
1
Nicotine Replacement Therapy
1
Nicotine Chewing Gum
1
Focus Groups
1
Ethanol
1
Educational Status
1
Dosage Forms
1
Cognitive Behavioral Therapy
1
Behavior Therapy
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Substance-Related Disorders
×
Patient Reported Outcome Measures
×
Clear all
NCT05684939
2023-06-13
CAPS
University Hospital, Clermont-Ferrand
Completed
2,010 enrolled